SAIBR
SAIBR performs regression-based spectral autofluorescence correction to enable accurate quantification of fluorescent proteins such as GFP and mNeonGreen in imaging of endogenously tagged proteins (e.g., via CRISPR/Cas9).
Key Features:
- Regression-based correction: Uses regression to model and remove autofluorescence contributions from spectral image data.
- Standard filter sets and illumination: Operates using standard filter sets and illumination conditions for spectral measurements.
- Platform independence: Applies across different microscopy setups without reliance on specialized hardware.
- Enhanced signal quantification: Improves detection and accurate quantitation of weak fluorophore signals obscured by autofluorescence.
- Validation across model systems: Has been validated in C. elegans embryos, starfish oocytes, and fission yeast.
Scientific Applications:
- Quantitative endogenous protein measurement: Enables accurate measurement of protein expression from endogenously tagged genes, including low-expression targets.
- Fluorescent protein imaging: Improves signal separation and quantitation for GFP and mNeonGreen where emission overlaps with tissue autofluorescence.
- Developmental and cell biology imaging: Facilitates fluorescence-based assays in embryos, oocytes, and yeast by reducing autofluorescence interference.
- CRISPR/Cas9-based tagging studies: Supports imaging studies that rely on endogenous fluorescent tagging to monitor proteins under native regulation.
Methodology:
Performs spectral autofluorescence correction by regression using measurements from standard filter sets and illumination conditions.
Topics
Details
- License:
- CC-BY-4.0
- Cost:
- Free of charge
- Tool Type:
- plugin
- Operating Systems:
- Mac, Linux, Windows
- Programming Languages:
- Java
- Added:
- 9/17/2022
- Last Updated:
- 11/24/2024
Operations
Publications
Rodrigues NTL, Bland T, Borrego-Pinto J, Ng K, Hirani N, Gu Y, Foo S, Goehring NW. SAIBR: a simple, platform-independent method for spectral autofluorescence correction. Development. 2022;149(14). doi:10.1242/dev.200545. PMID:35713287. PMCID:PMC9445497.
DOI: 10.1242/dev.200545
PMID: 35713287
PMCID: PMC9445497
Funding: - Cancer Research UK: FC001086
- Medical Research Council: FC001086
- Wellcome Trust: 220790/Z/20/Z, FC001086
- Biotechnology and Biological Sciences Research Council: BB/T000481/1
Documentation
Related Tools
imagej
Relation: uses